PTH and chronic kidney disease: All-cause mortality adjustment for age, gender, age ranking (young vs. older), and baseline PTH revealed no significant difference between the two groups, but when adjusting for the primary cause of CKD, patients on cinacalcet with HYT and DM + HYT etiology benefit from cinacalcet because they have lower HR.